Total planned funding: $124,473,686
Allocations
Countries/Regions
India | $124,473,686 |
Organizational Types
Unknown | $47,926,637 |
NGO | $35,950,064 |
Own Agency | $19,900,688 |
University | $8,990,217 |
Private Contractor | $4,098,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,206,808 |
Host Country Government Agency | $1,201,000 |
FBO | $1,100,000 |
Other USG Agency | $0 |
Program Areas
Governance and Systems | $61,398,374 |
Prevention | $23,284,817 |
Management and Operations | $15,779,728 |
Care | $9,596,413 |
Treatment | $5,641,586 |
Testing | $4,344,976 |
Budget Codes
OHSS: Health Systems Strengthening | $39,059,723 |
HVSI: Strategic Information | $18,467,717 |
HVMS: Management and Operations | $15,779,728 |
HVOP: Sexual Prevention: Other Sexual Prevention | $12,516,019 |
HTXS: Treatment: Adult Treatment | $5,261,315 |
HBHC: Care: Adult Care and Support | $4,878,465 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,612,626 |
HVCT: Testing: HIV Testing and Counseling | $4,344,976 |
HLAB: Laboratory Infrastructure | $3,870,934 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,452,379 |
HKID: Care: Orphans and Vulnerable Children | $2,769,846 |
HVTB: Care: TB/HIV | $1,688,085 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,663,552 |
HMBL: Biomedical Prevention: Blood Safety | $1,040,241 |
PDTX: Treatment: Pediatric Treatment | $356,794 |
PDCS: Care: Pediatric Care and Support | $260,017 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$47,926,637
Countries/Regions
FHI 360:
$16,042,311
Countries/Regions
USG Aggregated Agencies:
$13,907,789
Countries/Regions
Voluntary Health Services:
$5,260,000
Countries/Regions
University of Washington:
$4,450,000
Countries/Regions